无症状脑脊液HIV-1逃逸:发生率与后果
在瑞典HIV队列中纵向随访173例神经无症状、接受抗病毒治疗至少6个月且血浆病毒载量抑制的HIV感染者,无症状脑脊液逃逸(CSFE)按50拷贝/mL cutoff见于4例(2%)和5/449份样本(1%),按20拷贝/mL cutoff则为8%的感染者和4%的样本。CSFE样本脑脊液新蝶呤几何均值高25%(P=.01)、白蛋白比值高8%(P=.04),脑脊液白细胞≥3个/μL的比值比为3.9(P=.004),但神经丝轻链蛋白无差异(P=.8)。
要点
- 无症状CSFE按50拷贝/mL cutoff仅见于4例(2%)感染者,未见持续CSFE病例。
- CSFE样本脑脊液新蝶呤几何均值高25%(P=.01),白蛋白比值高8%(P=.04)。
- CSFE样本脑脊液白细胞≥3个/μL的比值比为3.9(P=.004),脑脊液NfL无差异(P=.8)。
核心结论
- 无症状CSFE仅见于4例(2%)HIV感染者,未观察到持续CSFE病例。
- 脑脊液HIV-1 RNA升高与中枢神经系统免疫激活及血脑屏障受损的生物标志物相关,但与神经元损伤的生物标志物无关。
研究设计与样本
- 瑞典HIV队列纵向随访研究,纳入接受抗病毒治疗至少6个月且血浆病毒载量抑制的神经无症状HIV感染者173例,配对脑脊液与血浆样本449份。
- CSFE定义为血浆病毒载量抑制时脑脊液HIV-1 RNA升高,或两者均可定量时脑脊液HIV-1 RNA超过血浆。
- 配对脑脊液与血浆检测HIV-1 RNA、新蝶呤、神经丝轻链蛋白(NfL)、白细胞计数和白蛋白比值。
主要发现
- 无症状CSFE(cutoff 50拷贝/mL)见于4/173例感染者(2%)和5/449份样本(1%)。
- 采用20拷贝/mL cutoff时,CSFE见于8%的感染者和4%的样本。
- CSFE样本(cutoff 20拷贝/mL)脑脊液新蝶呤几何均值较无CSFE样本高25%(P=.01),白蛋白比值高8%(P=.04)。
- CSFE样本与无CSFE样本脑脊液NfL水平无差异(P=.8)。
- CSFE样本脑脊液白细胞升高(≥3个/μL)的比值比为3.9(P=.004),对照为脑脊液病毒载量未升高样本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence and clinical relevance of asymptomatic cerebrospinal fluid escape (CSFE) during antiretroviral therapy (ART) is uncertain. We examined the impact and incidence of asymptomatic CSFE in a Swedish HIV cohort. METHODS: Neuroasymptomatic people with HIV (PWH) who have been on ART for at least 6 months with suppressed plasma viral load were followed longitudinally. CSFE was defined as either increased CSF HIV-1 RNA with concurrent plasma suppression or CSF HIV-1 RNA exceeding that in plasma when both were quantifiable. Paired CSF and plasma were analyzed for HIV-1 RNA, neopterin, neurofilament light protein (NfL), white blood cell (WBC) count, and albumin ratio. RESULTS: Asymptomatic CSFE (cutoff 50 copies/mL) was found in 4 of 173 PWH (2%) and 5 of 449 samples (1%). The corresponding proportions were 8% of PWH and 4% for samples using a 20 copies/mL cutoff for CSF HIV-1 RNA. CSFE samples (cutoff 20 copies/mL) had a 25% higher geometric mean of CSF neopterin (P = .01) and 8% higher albumin ratio (P = .04) compared to samples without CSFE. No differences were observed in CSF NfL levels (P = .8). The odds ratio for increased CSF WBC (≥ 3 cells/μL) in samples with CSFE was 3.9 (P = .004), compared to samples without elevated CSF viral load. CONCLUSIONS: Asymptomatic CSFE was identified in only 4 (2%) PWH, with no cases of continuous CSFE observed. Increased CSF HIV-1 RNA was associated with biomarkers of CNS immune activation and blood-brain barrier impairment, but not with biomarkers of neuronal injury.
引用
- Ulfhammer G, Yilmaz A, Mellgren Å, et al. Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences. J Infect Dis. 2025. PMID: 39531854. doi:10.1093/infdis/jiae555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。